Search

everythinglearnresearchcommunity

for

Search:↓

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Lespedeza cuneata extract may help treat enlarged prostate.

Finasteride and dutasteride both increase chromogranin A levels similarly.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The ethosomal formulation improved finasteride delivery through the skin.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Saw palmetto extract safely improves hair growth and reduces hair loss.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Ruxolitinib treatment may cause eyelash growth.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

5α-Reductase inhibitors don't cause depression.

Pacing leaf extracts can promote hair growth in rabbits, but minoxidil works better.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Finasteride can cause a unique skin reaction on the penile shaft.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.